Clinical guidance for e-cigarette (vaping) cessation: Results from a modified Delphi panel approach
- PMID: 37654515
- PMCID: PMC10466900
- DOI: 10.1016/j.pmedr.2023.102372
Clinical guidance for e-cigarette (vaping) cessation: Results from a modified Delphi panel approach
Abstract
Individuals seek help to stop their use of e-cigarettes from their healthcare practitioners. However, there is a paucity of published work addressing e-cigarette cessation methods empirically, and what evidence that is available is weak. Therefore, we developed an expert informed clinical resource to guide practitioners helping their clients quit using e-cigarettes. We conducted a modified Delphi process between September and December 2021 to reach consensus on clinical recommendations for e-cigarette cessation. Expert and Peer Panel members (n = 28) voted and provided feedback on the recommendations through three rounds of structured surveys, a discussion board, and one intermediate survey. The penultimate knowledge products underwent usability testing and were finalized based on user feedback. The Expert Panel maintained a 100% response rate for rounds 1 and 2 and 96% for round 3; the Peer Panel achieved a 100% response rate for all three rounds of the modified Delphi process. Consensus was reach on 24 recommendations and 2 statements spanning eight domains: severity and dependence; general approaches; treatment approaches; dual use; pharmacotherapy strategies; behavioural therapy strategies; harm reduction; and relapse prevention. Two additional 'no agreement' statements that did not reach consensus are included in the guidance resource. The recommendations were also contextualized for the following groups: adults; youth; people who are pregnant, breastfeeding and/or chestfeeding; and people with mental illness and/or substance use issues. The recommendations listed in the resource provide general clinical guidance on e-cigarette cessation to assist healthcare practitioners in the treatment planning process.
Keywords: Addiction medicine; Combustible tobacco; Delphi; Dual use; E-cigarette; Guidance; Smoking; Vaping; Vaping cessation.
© 2023 Centre for Addiction and Mental Health, University of Toronto. Published by Elsevier Inc.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: PS declares being a Member, Youth Vaping Cessation Advisory Group, University of Toronto, and reports funding received for e-cigarette research from Canadian Institutes of Health Research and the Ontario Ministry of Health. LZ declares providing an expert report on vaping to Cambridge LLP and reports receiving funding for e-cigarette research from the Ontario Ministry of Health and CAMH womenmind. EK, CF, RD and SV declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- American Association of Pediatrics. Nicotine Replacement Therapy and Adolescent Patients: Information for Pediatricians [Internet]. 2019 [2022 Oct 12]. Available from: https://downloads.aap.org/RCE/NRT_and_Adolescents_Pediatrician_Guidance_....
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders [Internet]. 5th ed. Washington (DC); 2013 [2022 Oct 12]. Available from: 10.1176/appi.books.9780890425596.
-
- Canadian Public Health Association. Tobacco and Vaping Use in Canada [Internet]. Ottawa (ON): Canada Public Health Association; 2021 [2022 Sept 9]. Available from: https://www.cpha.ca/tobacco-and-vaping-use-canada-moving-forward.
LinkOut - more resources
Full Text Sources
